<table border="0" cellpadding="2" cellspacing="1" id="Table1" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin Hydrochloride Tablets</caption>
<col span="1" width="40%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="17.5%"></col>
<col span="1" width="25%"></col>
<tbody>
<tr>
<th colspan="1">
<content stylecode="bold">Subject
Groups: Metformin Hydrochloride Tablets dose<sup>a</sup>
<br/>(number of
subjects)</content>
</th>
<th colspan="1">
<content stylecode="bold">C<sub>max</sub>
<sup>b</sup>
<br/>(µg/mL)</content>
</th>
<th colspan="1">
<content stylecode="bold">T<sub>max</sub>
<sup>c</sup>
<br/>(hrs)</content>
</th>
<th colspan="1">
<content stylecode="bold">Renal
Clearance<br/>(mL/min)</content>
</th>
</tr>
<tr>
<td>
<content stylecode="bold">Healthy, nondiabetic adults:</content>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>   500
mg single dose (24) </td>
<td>1.03 (±0.33)</td>
<td>2.75 (±0.81)</td>
<td>600 (±132)</td>
</tr>
<tr>
<td>   850
mg single dose (74)<sup>d</sup>
</td>
<td>1.60 (±0.38)</td>
<td>2.64 (±0.82)</td>
<td>552 (±139)</td>
</tr>
<tr>
<td>   850
mg three times daily for 19 doses<sup>e</sup> (9)</td>
<td>2.01 (±0.42)</td>
<td>1.79 (±0.94)</td>
<td>642 (±173)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Adults with type 2 diabetes:</content>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>   850
mg single dose (23)</td>
<td>1.48 (±0.5)</td>
<td>3.32 (±1.08)</td>
<td>491 (±138)</td>
</tr>
<tr>
<td>   850
mg three times daily for 19 doses<sup>e</sup> (9)</td>
<td>1.90 (±0.62)</td>
<td>2.01 (±1.22)</td>
<td>550 (±160)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Elderly<sup>f</sup>,
healthy nondiabetic adults:</content>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>   850
mg single dose (12)</td>
<td>2.45 (±0.70)</td>
<td>2.71 (±1.05)</td>
<td>412 (±98)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Renal-impaired adults:</content>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>
<content stylecode="bold">850 mg single dose</content>
</td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>    <content stylecode="bold">Mild</content> (CL<sub>cr</sub>
<sup>g</sup> 61-90 mL/min) (5)</td>
<td>1.86 (±0.52)</td>
<td>3.20 (±0.45)</td>
<td>384 (±122)</td>
</tr>
<tr>
<td>    <content stylecode="bold">Moderate</content> (CL<sub>cr</sub> 31-60 mL/min) (4) </td>
<td>4.12 (±1.83)</td>
<td>3.75 (±0.50)</td>
<td>108 (±57)</td>
</tr>
<tr>
<td>    <content stylecode="bold">Severe</content> (CL<sub>cr</sub> 10-30 mL/min) (6)</td>
<td>3.93 (±0.92)</td>
<td>4.01 (±1.10)</td>
<td>130 (±90)</td>
</tr>
</tbody>
</table>